Elena López-Cancio1, Ana Clara Ricciardi2, Tomás Sobrino3, Jordi Cortés4, Natalia Pérez de la Ossa2, Mónica Millán2, María Hernández-Pérez2, Meritxell Gomis2, Laura Dorado2, Lucía Muñoz-Narbona2, Francisco Campos3, Juan F Arenillas5, Antoni Dávalos2. 1. Department of Neuroscience, Hospital Germans Trias i Pujol, Universidad Autónoma Barcelona (UAB), Badalona, Barcelona, Spain. Electronic address: elenacancio@gmail.com. 2. Department of Neuroscience, Hospital Germans Trias i Pujol, Universidad Autónoma Barcelona (UAB), Badalona, Barcelona, Spain. 3. Clinical Neurosciences Research Laboratory, Department of Neurology, Hospital Clínico Universitario, Health Research Institute of Santiago de Compostela (IDIS), University of Santiago de Compostela, Santiago de Compostela, Spain. 4. Department of Biostatistics, Universitat Politècnica de Catalunya, Barcelona, Spain. 5. Department of Neurology, Hospital Clínico, University of Valladolid, Valladolid, Spain.
Abstract
INTRODUCTION: Physical activity (PhA) prior to stroke has been associated with good outcomes after the ischemic insult, but there is scarce data on the involved molecular mechanisms. METHODS: We studied consecutive acute ischemic stroke patients admitted to a single tertiary stroke center. Prestroke PhA was evaluated with the International Physical Activity Questionnaire (metabolic equivalent of minutes/week). We studied several circulating angiogenic and neurogenic factors at different time points: vascular endothelial growth factor (VEGF), granulocyte colony-stimulating factor (G-CSF), and brain-derived neurotrophic factor (BDNF) at admission, day 7, and at 3 months. We considered good functional outcome at 3 months (modified Rankin scale ≤ 2) as primary end point, and final infarct volume as secondary outcome. RESULTS: We studied 83 patients with at least 2 time point serum determinations (mean age 69.6 years, median National Institutes of Health Stroke Scale 17 at admission). Patients more physically active before stroke had a significantly higher increment of serum VEGF on the seventh day when compared to less active patients. This increment was an independent predictor of good functional outcome at 3 months and was associated with smaller infarct volume in multivariate analyses adjusted for relevant covariates. We did not find independent associations of G-CSF or BDNF levels neither with level of prestroke PhA nor with stroke outcomes. CONCLUSIONS: Although there are probably more molecular mechanisms by which PhA exerts its beneficial effects in stroke outcomes, our observation regarding the potential role of VEGF is plausible and in line with previous experimental studies. Further research in this field is needed.
INTRODUCTION: Physical activity (PhA) prior to stroke has been associated with good outcomes after the ischemic insult, but there is scarce data on the involved molecular mechanisms. METHODS: We studied consecutive acute ischemic strokepatients admitted to a single tertiary stroke center. Prestroke PhA was evaluated with the International Physical Activity Questionnaire (metabolic equivalent of minutes/week). We studied several circulating angiogenic and neurogenic factors at different time points: vascular endothelial growth factor (VEGF), granulocyte colony-stimulating factor (G-CSF), and brain-derived neurotrophic factor (BDNF) at admission, day 7, and at 3 months. We considered good functional outcome at 3 months (modified Rankin scale ≤ 2) as primary end point, and final infarct volume as secondary outcome. RESULTS: We studied 83 patients with at least 2 time point serum determinations (mean age 69.6 years, median National Institutes of Health Stroke Scale 17 at admission). Patients more physically active before stroke had a significantly higher increment of serum VEGF on the seventh day when compared to less active patients. This increment was an independent predictor of good functional outcome at 3 months and was associated with smaller infarct volume in multivariate analyses adjusted for relevant covariates. We did not find independent associations of G-CSF or BDNF levels neither with level of prestroke PhA nor with stroke outcomes. CONCLUSIONS: Although there are probably more molecular mechanisms by which PhA exerts its beneficial effects in stroke outcomes, our observation regarding the potential role of VEGF is plausible and in line with previous experimental studies. Further research in this field is needed.
Authors: Arun S Mahadevan; Byron L Long; Chenyue W Hu; David T Ryan; Nicolas E Grandel; George L Britton; Marisol Bustos; Maria A Gonzalez Porras; Katerina Stojkova; Andrew Ligeralde; Hyeonwi Son; John Shannonhouse; Jacob T Robinson; Aryeh Warmflash; Eric M Brey; Yu Shin Kim; Amina A Qutub Journal: PLoS Comput Biol Date: 2022-06-13 Impact factor: 4.779
Authors: Daniel Aggio; Efstathios Papachristou; Olia Papacosta; Lucy T Lennon; Sarah Ash; Peter H Whincup; S Goya Wannamethee; Barbara J Jefferis Journal: Int J Behav Nutr Phys Act Date: 2018-02-07 Impact factor: 6.457
Authors: Sara Botö; Dongni Johansson Buvarp; Per-Olof Hansson; Katharina S Sunnerhagen; Carina U Persson Journal: J Rehabil Med Date: 2021-09-09 Impact factor: 2.912